Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

NCT: NCT04088071 · RECRUITING

NCT IDNCT04088071
StatusRECRUITING
Start Date2018-01-01
Completion2028-12-31
SponsorHeart Rhythm Clinical and Research Solutions, LLC (OTHER)
First posted
Last updated

Brief Summary

The primary purpose of this Registry is to assess procedural safety and long-term effectiveness of catheter ablations in the treatment of subjects with PAF, PsAF, and VA. The Registry will utilize real world clinical data obtained from the use of commercially available CARTO™ technologies under the authority of a health care practitioner within a legitimate practitioner-subject relationship. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term effectiveness of catheter ablation with novel technologies for arrhythmia patients.

Frequently Asked Questions

What is Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias?

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias is a clinical trial registered under NCT04088071. Current status: RECRUITING.

What is the status of NCT04088071?

The current status of NCT04088071 (Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias) is: RECRUITING.

When did Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias start?

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias started on 2018-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.